Omnicol

Macrogol 3350, the active ingredient in Omnicol, is an osmotic laxative presented as an oral solution for oral use. It is used to relieve constipation and to prepare the bowel for diagnostic procedures in adults.

GNH USA supplies Omnicol as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omnicol, containing macrogol 3350 and electrolyte salts, is employed in gastrointestinal management.

Constipation: provides osmotic laxation to facilitate stool passage in adults. Bowel preparation: cleanses the colon before colonoscopy or radiologic imaging. Electrolyte replacement: restores fluid and electrolyte balance in patients with mild dehydration.

Common Side Effects: - Abdominal bloating - Nausea - Flatulence - Diarrhea - Abdominal cramps - Headache

Serious or Rare Side Effects: - Severe dehydration - Electrolyte imbalance (hypernatremia, hyperkalemia) - Allergic reaction (rash, itching, swelling) - Severe abdominal pain - Rectal bleeding - Acute renal impairment

Precautions should be observed when using Omnicol to minimize risks.

Assess renal function: adjust use in severe renal impairment. Monitor electrolytes: avoid in patients with existing electrolyte disorders. Avoid in bowel obstruction: contraindicated in mechanical blockage. Use caution in elderly: increased risk of dehydration. Pregnancy: limited data, use only if clearly needed. Store at ambient temperature: keep in the original container, protect from moisture.

Omnicol may interact with other medicines; awareness of major and moderate interactions is important.

Major Interactions (Avoid): - Sodium-containing medications: risk of hypernatremia. - Potassium-sparing diuretics: may cause hyperkalemia. - Other osmotic laxatives: additive effect leading to severe diarrhea.

Moderate Interactions (Monitor Closely): - Antacids: may affect absorption of electrolytes. - Lithium: altered renal clearance may increase toxicity. - ACE inhibitors: monitor potassium levels closely.